ENTRY       D02721                      Drug
NAME        Iloprost (USAN/INN);
            Ventavis (TN)
PRODUCT     VENTAVIS (Actelion Pharmaceuticals US)
FORMULA     C22H32O4
EXACT_MASS  360.2301
MOL_WEIGHT  360.4871
CLASS       Blood modifier agent
             DG01950  Antithrombotic agent
              DG01712  Antiplatelet agent
            Hormonal agent
             DG01961  Prostaglandin derivative
              DG01810  Prostacycline derivative
REMARK      Therapeutic category: 2190
            ATC code: B01AC11
            Chemical structure group: DG00158
            Product (DG00158): D02721<JP/US>
EFFICACY    Antihypertensive, Platelet aggregation inhibitor, Prostaglandin I2 receptor agonist
  DISEASE   Pulmonary arterial hypertension [DS:H01621]
COMMENT     Prostacycline derivative
            Treatment of pulmonary hypertension
TARGET      PTGIR [HSA:5739] [KO:K04263]
  PATHWAY   hsa04080(5739)  Neuroactive ligand-receptor interaction
            hsa04270(5739)  Vascular smooth muscle contraction
            hsa04611(5739)  Platelet activation
INTERACTION  
STR_MAP     map07034  Eicosanoids
            map07228  Eicosanoid receptor agonists/antagonists
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             B BLOOD AND BLOOD FORMING ORGANS
              B01 ANTITHROMBOTIC AGENTS
               B01A ANTITHROMBOTIC AGENTS
                B01AC Platelet aggregation inhibitors excl. heparin
                 B01AC11 Iloprost
                  D02721  Iloprost (USAN/INN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Respiratory Tract/Pulmonary Agents
              Pulmonary Antihypertensives
               Prostacyclin Vasodilators
                Iloprost
                 D02721  Iloprost (USAN/INN)
            Therapeutic category of drugs in Japan [BR:br08301]
             2  Agents affecting individual organs
              21  Cardiovascular agents
               219  Miscellaneous
                2190  Miscellaneous
                 D02721  Iloprost (USAN/INN)
            Drug groups [BR:br08330]
             Blood modifier agent
              DG01950  Antithrombotic agent
               DG01712  Antiplatelet agent
                DG00158  Iloprost
                 D02721  Iloprost
             Hormonal agent
              DG01961  Prostaglandin derivative
               DG01810  Prostacycline derivative
                DG00158  Iloprost
                 D02721  Iloprost
            Target-based classification of drugs [BR:br08310]
             G Protein-coupled receptors
              Rhodopsin family
               Prostacyclin
                PTGIR
                 D02721  Iloprost (USAN/INN) &lt;JP/US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D02721
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D02721
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D02721
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D02721
            Drug groups [BR:br08330]
             Blood modifier agent
              DG01950  Antithrombotic agent
               DG01712  Antiplatelet agent
                DG00158  Iloprost
             Hormonal agent
              DG01961  Prostaglandin derivative
               DG01810  Prostacycline derivative
                DG00158  Iloprost
DBLINKS     CAS: 78919-13-8
            PubChem: 17396888
            ChEBI: 63916
            LigandBox: D02721
            NIKKAJI: J685.840F
ATOM        26
            1   C1x C     8.0500  -25.0600
            2   C1y C     8.8900  -26.1800
            3   C1y C    10.2200  -25.6900
            4   C1y C    10.2200  -24.2900
            5   C1y C     8.8900  -23.8700
            6   O1a O     8.4000  -27.5100
            7   C1x C    11.0600  -23.1700
            8   C2y C    10.2200  -22.0500
            9   C1x C     8.8900  -22.4700
            10  C2b C    11.4800  -26.3900
            11  C2b C    12.6700  -25.6900
            12  C1c C    13.8600  -26.3900
            13  C1c C    15.0500  -25.7600
            14  C1b C    16.2400  -26.3900
            15  C1a C    15.0500  -24.2900
            16  C3b C    17.4300  -25.7600
            17  C3b C    18.6900  -25.0600
            18  C1a C    19.8800  -24.3600
            19  O1a O    13.8600  -27.8600
            20  C2b C    10.6480  -20.7170
            21  C1b C     9.7055  -19.6775
            22  C1b C     8.3621  -19.9679
            23  C1b C     7.3986  -18.9047
            24  C6a C     6.0516  -19.1956
            25  O6a O     5.0897  -18.1338
            26  O6a O     5.6246  -20.5230
BOND        27
            1     1   2 1
            2     2   3 1
            3     3   4 1
            4     4   5 1
            5     1   5 1
            6     2   6 1 #Down
            7     4   7 1 #Down
            8     7   8 1
            9     8   9 1
            10    5   9 1 #Down
            11    3  10 1 #Up
            12   10  11 2
            13   11  12 1
            14   12  13 1
            15   13  14 1
            16   13  15 1
            17   14  16 1
            18   16  17 3
            19   17  18 1
            20   12  19 1 #Down
            21    8  20 2
            22   20  21 1
            23   21  22 1
            24   22  23 1
            25   23  24 1
            26   24  25 1
            27   24  26 2
///
